BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Healthcare | 6.75% |
| 3 | Financials | 5.74% |
| 4 | Consumer Discretionary | 5.28% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
3276
DELISTED
Mersana Therapeutics
MRSN
| $64.8K | ﹤0.01% |
445
+99
| +29% | +$17.3K |
|
|
RVI
3277
DELISTED
Retail Value Inc. Common Shares
RVI
| $64.3K | ﹤0.01% |
57,217
+16,167
| +39% | +$42.2K |
|
3278
Carter Bankshares
CARE
$764M
| $64K | ﹤0.01% |
6,970
+1,468
| +27% | +$25.1K |
|
|
WPG
3279
DELISTED
Washington Prime Group Inc.
WPG
| $63.6K | ﹤0.01% |
8,780
-743
| -8% | -$17.5K |
|
|
ORC
3280
Orchid Island Capital
ORC
$1.33B
| $63.5K | ﹤0.01% |
4,305
+1,720
| +67% | +$46.5K |
|
3281
National Bankshares
NKSH
$269M
| $63.4K | ﹤0.01% |
1,988
+420
| +27% | +$16.1K |
|
3282
Regis Corp
RGS
$70M
| $63.4K | ﹤0.01% |
536
-3
| -0.6% | -$781 |
|
|
SYRS
3283
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $63.4K | ﹤0.01% |
1,069
+668
| +167% | +$45.3K |
|
3284
KRONOS Worldwide
KRO
$977M
| $63.3K | ﹤0.01% |
7,496
+1,496
| +25% | +$15.7K |
|
|
BRSL
3285
Brightstar Lottery PLC
BRSL
$2.16B
| $63.3K | ﹤0.01% |
10,632
+5,631
| +113% | +$64.2K |
|
3286
Limoneira
LMNR
$251M
| $63.2K | ﹤0.01% |
4,826
+1,547
| +47% | +$27.8K |
|
3287
Village Super Market
VLGEA
$636M
| $63.1K | ﹤0.01% |
2,567
+549
| +27% | +$12.1K |
|
3288
Pure Cycle
PCYO
$274M
| $62.6K | ﹤0.01% |
5,612
+3,199
| +133% | +$38.8K |
|
3289
Southern First Bancshares
SFST
$610M
| $62.4K | ﹤0.01% |
2,200
+494
| +29% | +$18.4K |
|
3290
Hingham Institution for Saving
HIFS
$682M
| $62.2K | ﹤0.01% |
429
+165
| +63% | +$30.9K |
|
|
HUD
3291
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $61.9K | ﹤0.01% |
12,322
+1,441
| +13% | +$14.3K |
|
3292
Old Second Bancorp
OSBC
$1.32B
| $61.8K | ﹤0.01% |
8,944
+2,008
| +29% | +$22.1K |
|
|
GHL
3293
DELISTED
Greenhill & Co., Inc.
GHL
| $61.3K | ﹤0.01% |
6,227
+1,710
| +38% | +$25K |
|
3294
Applied Optoelectronics
AAOI
$12.7B
| $61.3K | ﹤0.01% |
8,072
-73
| -0.9% | -$770 |
|
3295
Grocery Outlet
GO
$1.05B
| $61.3K | ﹤0.01% |
1,784
+356
| +25% | +$11.6K |
|
3296
Atlanta Braves Holdings Series A
BATRA
$3.63B
| $61.2K | ﹤0.01% |
3,138
+1,626
| +108% | +$41.9K |
|
|
TEN
3297
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $61K | ﹤0.01% |
16,941
-2,563
| -13% | -$21.5K |
|
3298
First Trust Cloud Computing ETF
SKYY
$3.32B
| $60.7K | ﹤0.01% |
+1,114
| New | +$67.6K |
|
3299
ADMA Biologics
ADMA
$2.1B
| $60.7K | ﹤0.01% |
21,068
+15,219
| +260% | +$52.6K |
|
3300
OneSpaWorld
OSW
$2.74B
| $60.5K | ﹤0.01% |
14,897
+2,951
| +25% | +$35.5K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.